ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:ProMIS Neurosciences Inc (PMN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010916
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company Epitope Protection and AMFIA has two therapeutic programs: Alzheimer’s therapeutic tau program and ALS therapeutic TD4P3 program. The company’s products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. ProMIS is headquartered in Toronto, Ontario, Canada.

ProMIS Neurosciences Inc (PMN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
ProMIS Neurosciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer’s Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
Equity Offering 16
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 20
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 21
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 22
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 23
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 24
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 27
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 28
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 29
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 31
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 32
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 33
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 35
ProMIS Neurosciences Inc – Key Competitors 37
ProMIS Neurosciences Inc – Key Employees 38
ProMIS Neurosciences Inc – Locations And Subsidiaries 39
Head Office 39
Recent Developments 40
Financial Announcements 40
Nov 13, 2017: ProMIS Neurosciences Announces Third Quarter 2017 Results 40
Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 42
Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 44
May 09, 2017: ProMIS Neurosciences Announces Q1 2017 Quarterly Results 45
Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 46
Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 47
Nov 02, 2016: ProMIS Neurosciences Announces Third Quarter 2016 Results 49
Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results 51
May 11, 2016: ProMIS Neurosciences announces first quarter 2016 results 53
Mar 23, 2016: ProMIS Neurosciences announces FY2015 year end results 54
Corporate Communications 57
Jun 06, 2017: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board 57
Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 58
Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 59
Oct 18, 2016: ProMIS Neurosciences announces appointment of Dr. Richard Gregory to its Board of Directors 60
Jul 21, 2016: ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer 61
Jan 26, 2016: ProMIS Neurosciences announces formation of prestigious Scientific Advisory and Business Advisory Boards 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
ProMIS Neurosciences Inc, Medical Equipment, Key Facts, 2016 2
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
ProMIS Neurosciences Inc, Deals By Market, 2011 to YTD 2017 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 20
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 21
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 22
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 23
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 24
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 27
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 28
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 29
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 31
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 32
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 33
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 35
ProMIS Neurosciences Inc, Key Competitors 37
ProMIS Neurosciences Inc, Key Employees 38

★海外企業調査レポート[ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Advanced Catheter Therapies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Advanced Catheter Therapies Inc (ACT) is a medical device company that provides novel catheter technologies targeting vascular disease such as inflammation, thrombosis, occlusions and restenosis. The company is developing a device for restenosis and catheters for endovascular debulking. It o …
  • Ryanair Holdings plc:企業の戦略・SWOT・財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nayara Energy Ltd.:企業の戦略・SWOT・財務分析
    Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Foraco International SA (FAR):企業の財務・戦略的SWOT分析
    Summary Foraco International SA (Foraco) is a provider of drilling solutions for mining, energy, water and infrastructure projects. The company's drilling solutions include hydrogeological drilling, deep directional drilling, metallurgical sampling and large diameter drilling. It provides geological …
  • Companhia Energetica de Sao Paulo (CESP6):企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Foundation Radiology Group PC:医療機器:M&Aディール及び事業提携情報
    Summary Foundation Radiology Group PC (FRG) is a provider of radiology solutions. The company offers radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It offers imaging solutions for the radiologists and systems …
  • WPP Plc (WPP):企業の財務・戦略的SWOT分析
    WPP Plc (WPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • SDIX LLC:医療機器:M&Aディール及び事業提携情報
    Summary SDIX LLC (SDIX), a subsidiary of OriGene Technologies Inc, is an immuno-solutions company that develops antibody-based solutions. The company provides IVD solutions and premade antibiotics, among others. Its IVD solutions provide co-development of analyte-specific reagents, diagnostic menu e …
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • FPT Securities Joint Stock Company (FTS):企業の財務・戦略的SWOT分析
    FPT Securities Joint Stock Company (FTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Biocept Inc (BIOC):企業の製品パイプライン分析2018
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Cerus Energy Group Ltd (CEA):企業の財務・戦略的SWOT分析
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …
  • Horizon Discovery Group Plc (HZD):企業の財務・戦略的SWOT分析
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • PharmaCell BV-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCell BV (PharmaCell) is a contract manufacturing organization that offers services for cellular therapies and regenerative medicine. The organization manufactures commercial cell therapy products in the European markets. Its services include cell culture scale-up, manufacturing of adva …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Sumitomo Mitsui Banking Corp:企業のM&A・事業提携・投資動向
    Sumitomo Mitsui Banking Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sumitomo Mitsui Banking Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Havells India Ltd (HAVELLS)-エネルギー分野:企業M&A・提携分析
    Summary Havells India Limited (Havells) is a fast moving electrical goods (FMEG) company that carries out the design, production and distribution of a range of world class industrial and consumer electrical products. Its products include building circuit protection products, capacitors, cables and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆